Skip to main content
. 2020 Jul 24;44(11):3710–3719. doi: 10.1007/s00268-020-05705-w

Table 3.

Demographics and observed complications

Patient characteristics
(n = 317)
Distribution Observed complications n (%)
Age, mean 61.23 (SD 20.32) Serious complication 86 (27.1%)
Sex, males, n (%) 175 (55.2%) Any complication 127 (40.1%)
ASA class, mean 1.82 (SD 0.82) Pneumonia 41 (12.9%)
1, n (%) 136 (42.9%) Cardiac complication 34 (10.7%)
2, n (%) 108 (34.0%) SSI 53 (16.7%)
3, n (%) 69 (21.8%) UTI 9 (2.8%)
4, n (%) 4 (1.3%) VTE 2 (0.6%)
Height in meters, mean 1.69 (SD 0.09) Renal failure 21 (7.2%)
Weight in kg, mean 72.88 (SD 14.92) Readmission 8 (2.5%)
Functional Status Return to OR 23 (7.2%)
Independent, n (%) 239 (75.4%) Death 29 (9.2%)
Partially dependent, n (%) 72 (22.7%) Discharge to nursing or rehab facility 45 (14.2%)
Totally dependent, n (%) 6 (1.9%) Length of hospital stay, mean (days) 14.1 (SD 19.7)
Emergency case, n (%) 317 (100%)
Steroid Use, n (%) 8 (2.5%)
Ascites, n (%) 0 (0%)
Sepsis within 48 h, n (%) 103 (32.5%)
Ventilated, n (%) 0 (0%)
Diabetes, n (%) 92 (29.0%)
Hypertension, n (%) 97 (30.6%)
CHF, n (%) 11 (3.5%)
Dyspnea, n (%) 19 (6%)
Smoker, n (%) 52 (16.4%)
COPD, n (%) 17 (5.4%)
Dialysis, n (%) 5 (1.6%)
Acute renal failure, n (%) 7 (2.2%)

CHF chronic heart failure, COPD chronic obstructive pulmonary disease, SSI surgical site infection, UTI urinary tract infection, VTE venous thromboembolism